3 Followers on Owler
OverviewCompetitorsFundingNews & Insights

ClostraBio Competitors or Alternatives

ClostraBio's top competitors include Aimmune, DBV Technologies and ITI.

Unlock 4 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

ClostraBio's company profile

Ritu Shah

CEO

- -
1 - 25
$13.4M
$100K - 5M
  • $13.4M
    $100K - 5M
  • 1 - 25
    $13.4M
  • $100K - 5M
  • - -
  • 1 - 25
  • $13.4M
  • $100K - 5M
View ProfileView
1
ClostraBio's Competitor - Aimmune logo

Andrew Oxtoby

President & CEO

82/100
250 - 500
$720.5M
$5M - 25M
  • $720.5M
    $5M - 25M
  • 250 - 500
    $720.5M
  • $5M - 25M
  • 82/100
  • 250 - 500
  • $720.5M
  • $5M - 25M
View ProfileView
2
ClostraBio's Competitor - DBV Technologies logo

Daniel Tasse

CEO

88/100
125
$338M
$5M
  • $338M
    $5M
  • 125
    $338M
  • $5M
  • 88/100
  • 125
  • $338M
  • $5M
View ProfileView
3
ClostraBio's Competitor - ITI logo

Dong-Gun Kim

CEO

82/100
25 - 100
$106.2M
$5M - 25M
  • $106.2M
    $5M - 25M
  • 25 - 100
    $106.2M
  • $5M - 25M
  • 82/100
  • 25 - 100
  • $106.2M
  • $5M - 25M
View ProfileView
4
ClostraBio's Competitor - Dbversity logo

CEO

- -
- -
  • - -
  • - -
  • - -
  • - -
View ProfileView
5
ClostraBio's Competitor - Novo Nordisk logo

Maziar Mike Doustdar

President & CEO

79/100
77,349
- -
$44.8B
  • - -
    $44.8B
  • 77,349
    - -
  • $44.8B
  • 79/100
  • 77,349
  • - -
  • $44.8B
View ProfileView
ClostraBio's top 7 competitors are Aimmune, DBV Technologies, ITI, Agios, Dbversity, Novo Nordisk and IgGenix. Together they have raised over 1.5B between their estimated 78.3K employees. ClostraBio's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 6.4B. ClostraBio has 12 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 11,190.

ClostraBio VS Aimmune

Aimmune is one of ClostraBio's top rivals. Aimmune was founded in Brisbane, California} in 2011. Like ClostraBio, Aimmune also competes in the Pharmaceuticals & Biotechnology space. Compared to ClostraBio, Aimmune generates $13M more revenue.

ClostraBio VS DBV Technologies

DBV Technologies is ClostraBio's #2 competitor. DBV Technologies was founded in 2002, and is headquartered in Montrouge, Île-de-France. Like ClostraBio, DBV Technologies also operates in the Biotechnology space. DBV Technologies generates $3.5M more revenue vs. ClostraBio.

ClostraBio VS ITI

ITI is a top competitor of ClostraBio. ITI's headquarters is in Rockville, Maryland, and was founded in 2005. Like ClostraBio, ITI also works within the Biotechnology sector. ITI generates 333% of ClostraBio's revenue.

Looking for similar companies to ClostraBio?

Similar Companies

Biotechnology companies in Chicago

See 92 companies 
Biotechnology companies in Chicago Metropolitan Area

See 194 companies 
Pharmaceuticals & Biotechnology companies in Chicago

See 151 companies 
Biotechnology companies in Illinois

See 230 companies 
Pharmaceuticals & Biotechnology companies in Chicago Metropolitan Area

See 338 companies 
Pharmaceuticals & Biotechnology companies in Illinois

See 408 companies 
Companies in Chicago with employees in 1-25 range

See 2,957 companies 
Biotechnology companies with employees in 1-25 range

See 3,321 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,516 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for ClostraBio and ClostraBio's Competitors

August 17, 2026PharmaTimes
New alliance aims to accelerate development of future medicines...
August 16, 2026Zolmax News
SCS Capital Management LLC bought a new position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the 2nd quarter, according...
August 17, 2026STAT News
AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run of setbacks...
August 16, 2026Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $EXEL--EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law...
August 17, 2026Benzinga
AstraZeneca reports mixed lung cancer trial data, highlighting successes for Tagrisso and Enhertu while halting a volrustomig study.read more...
Today 12:08 AMBiopharminternational
The independent data monitoring committee's finding leaves clinicians without a new option for PD-L1-low NSCLC, a population historically underserved b...
August 17, 2026Inderes
EMERALD-3 late-breaking presentation will showcase benefit of Imfinzi and Imjudo in early liver cancer. Phase III data from SERENA-6, DESTINY-Breast09 ...

Frequently Asked Questions about ClostraBio

  1. Who are ClostraBio's top competitors?

    ClostraBio's top 3 competitors are Aimmune, DBV Technologies, ITI.

  2. Who is similar to ClostraBio?

    Aimmune is the most similar to ClostraBio. DBV Technologies and ITI are also similar to ClostraBio.

  1. Are ClostraBio and Aimmune competitors?

    Yes, Aimmune is one of ClostraBio’s top competitors.